- socially bharat
- September 12, 2024
CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients
Baar, Switzerland: CorFlow Therapeutics AG (CorFlow) announced today that it has raised €44 million in Series B funding, co-led by